To further confirm that the protective effect of diosmetin on myocardial remodeling is dependent on the p62-Keap1-Nrf2 signaling pathway, the cardioprotective effect of diosmetin on PE-induced cardiac hypertrophy disappeared by knocking down the p62 gene in NRCMs cells. The gene discussed is SQSTM1; the disease is cardiac hypertrophy.